STERIS plc (STE) Key Metrics
STE valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $21.71B
- Enterprise value
- $21.92B
- P/E (TTM)
- 27.2 10-yr median 38.9
- Forward P/E
- 19.2
- PEG ratio
- 1.74
- Price / sales
- 3.6 10-yr median 4.0
- Price / book
- 2.8 10-yr median 3.4
- EV / EBITDA
- 13.4 10-yr median 17.7
- Dividend yield
- 1.16% $2.58 a year
- Beta
- 0.93
STE key metrics, FY2017–FY2026
Fiscal year ended March 31, 2026 · U.S. dollarsSTE valuation Price multiples at each fiscal year-end price.
STE returns How much profit the business earns on the capital it uses.
STE per-share figures Results divided by the shares outstanding at year-end.
STE financial health Debt, liquidity and how easily interest is covered.
STE efficiency & capital use Working capital cycle and where the cash goes.
STE valuation history
STE returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
STE debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
STE cash returned to shareholders
STE price vs earnings per share
STE key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $21.83B | $22.45B | $22.34B | $19.18B | $23.77B | $16.36B | $11.99B | $10.94B | $8.00B | $5.98B |
| Enterprise value | $23.47B | $24.48B | $25.51B | $22.08B | $26.70B | $17.81B | $12.84B | $11.96B | $9.19B | $7.25B |
| P/E ratio | 27.8 | 36.5 | 59.1 | 179.2 | 97.5 | 41.2 | 29.4 | 36.0 | 27.5 | 54.4 |
| Price / sales | 3.7 | 4.1 | 4.3 | 4.2 | 5.6 | 5.3 | 4.0 | 3.9 | 3.1 | 2.3 |
| Price / book | 3.0 | 3.4 | 3.5 | 3.2 | 3.6 | 4.2 | 3.5 | 3.4 | 2.5 | 2.1 |
| Price / free cash flow | 22.4 | 28.9 | 36.4 | 48.5 | 59.8 | 36.3 | 31.9 | 31.3 | 27.4 | 23.8 |
| Price / operating cash flow | 16.3 | 19.6 | 23.0 | 25.3 | 34.7 | 23.7 | 20.3 | 20.3 | 17.5 | 14.1 |
| EV / sales | 4.0 | 4.5 | 5.0 | 4.9 | 6.3 | 5.7 | 4.2 | 4.3 | 3.5 | 2.8 |
| EV / EBITDA | 14.7 | 18.0 | 18.1 | 16.2 | 26.5 | 23.0 | 17.4 | 18.7 | 15.7 | 17.4 |
| EV / free cash flow | 24.1 | 31.5 | 41.6 | 55.9 | 67.2 | 39.6 | 34.1 | 34.2 | 31.5 | 28.8 |
| Earnings yield | 3.6% | 2.7% | 1.7% | 0.6% | 1.0% | 2.4% | 3.4% | 2.8% | 3.6% | 1.8% |
| Free cash flow yield | 4.5% | 3.5% | 2.7% | 2.1% | 1.7% | 2.8% | 3.1% | 3.2% | 3.7% | 4.2% |
| Dividend yield | 1.1% | 1.0% | 0.9% | 1.0% | 0.7% | 0.8% | 1.0% | 1.0% | 1.3% | 1.6% |
| Shareholder yield (dividends + buybacks) | 2.2% | 1.9% | 1.0% | 2.6% | 0.9% | 0.9% | 1.5% | 1.8% | 2.1% | 3.2% |
| Share price at fiscal year-end | $221.13 | $226.65 | $224.82 | $191.28 | $241.77 | $190.48 | $139.97 | $128.03 | $93.36 | $69.46 |
| Per share | ||||||||||
| Revenue per share | $60.14 | $55.11 | $51.72 | $45.25 | $42.95 | $36.18 | $35.39 | $32.55 | $30.57 | $30.35 |
| Earnings per share | $7.95 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.56 | $3.39 | $1.28 |
| Operating cash flow per share | $13.59 | $11.59 | $9.80 | $7.55 | $6.96 | $8.03 | $6.90 | $6.31 | $5.34 | $4.93 |
| Free cash flow per share | $9.85 | $7.85 | $6.17 | $3.94 | $4.04 | $5.24 | $4.39 | $4.09 | $3.41 | $2.92 |
| Cash per share | $4.45 | $1.73 | $2.08 | $2.08 | $3.54 | $2.57 | $3.73 | $2.58 | $2.35 | $3.29 |
| Book value per share | $72.78 | $66.65 | $63.43 | $60.72 | $66.44 | $45.30 | $39.78 | $37.27 | $37.54 | $32.64 |
| Tangible book value per share | $13.87 | $6.59 | $1.13 | −$7.46 | −$12.21 | −$0.38 | $5.67 | $3.02 | $0.66 | −$1.70 |
| Dividends per share | $2.45 | $2.22 | $2.02 | $1.83 | $1.66 | $1.56 | $1.44 | $1.32 | $1.20 | $1.08 |
| Capex per share | $3.74 | $3.74 | $3.63 | $3.61 | $2.92 | $2.79 | $2.50 | $2.22 | $1.93 | $2.01 |
| Debt per share | $21.15 | $22.23 | $34.05 | $31.06 | $33.36 | $19.48 | $13.67 | $14.49 | $16.23 | $18.00 |
| Shares outstanding | 98.7M | 99.1M | 99.4M | 100.2M | 98.3M | 85.9M | 85.6M | 85.5M | 85.7M | 86.1M |
| Change in shares outstanding | −0.4% | −0.3% | −0.9% | +2.0% | +14.5% | +0.3% | +0.2% | −0.3% | −0.4% | +20.9% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 11.4% | 9.5% | 6.1% | 1.7% | 4.7% | 10.9% | 12.4% | 9.5% | 9.7% | 3.8% |
| Return on invested capital (ROIC) | 9.5% | 7.4% | 7.1% | 7.0% | 5.0% | 8.8% | 10.4% | 7.9% | 7.7% | 3.2% |
| Return on assets (ROA) | 7.5% | 5.8% | 3.5% | 1.0% | 2.7% | 6.6% | 7.8% | 5.9% | 5.7% | 2.1% |
| Return on tangible assets | 15.9% | 14.6% | 7.8% | 2.7% | 6.6% | 15.0% | 16.3% | 14.2% | 14.3% | 5.6% |
| Free cash flow margin | 16.4% | 14.3% | 11.9% | 8.7% | 9.4% | 14.5% | 12.4% | 12.6% | 11.2% | 9.6% |
| Income quality (OCF / net income) | 1.71 | 1.87 | 2.57 | 7.07 | 2.81 | 1.74 | 1.45 | 1.77 | 1.57 | 3.86 |
| Financial health | ||||||||||
| Total debt | $2.09B | $2.20B | $3.38B | $3.11B | $3.28B | $1.67B | $1.17B | $1.24B | $1.39B | $1.55B |
| Cash & short-term investments | $439.6M | $171.7M | $207.0M | $208.4M | $348.3M | $220.5M | $319.6M | $220.6M | $201.5M | $282.9M |
| Net debt | $1.65B | $2.03B | $3.18B | $2.91B | $2.93B | $1.45B | $850.7M | $1.02B | $1.19B | $1.27B |
| Debt / equity | 0.29 | 0.33 | 0.54 | 0.51 | 0.50 | 0.43 | 0.34 | 0.39 | 0.43 | 0.55 |
| Debt / assets | 0.19 | 0.22 | 0.31 | 0.29 | 0.29 | 0.25 | 0.22 | 0.24 | 0.27 | 0.31 |
| Net debt / EBITDA | 1.03 | 1.49 | 2.25 | 2.13 | 2.90 | 1.88 | 1.16 | 1.59 | 2.04 | 3.03 |
| Current ratio | 2.09 | 1.96 | 3.08 | 2.33 | 2.04 | 2.10 | 2.40 | 2.27 | 2.48 | 2.67 |
| Quick ratio | 1.54 | 1.39 | 2.36 | 1.53 | 1.41 | 1.55 | 1.91 | 1.82 | 1.97 | 2.15 |
| Interest coverage | 18.2 | 10.0 | 5.8 | 7.1 | 5.3 | 14.7 | 13.3 | 9.1 | 7.9 | 5.1 |
| Working capital | $1.25B | $978.6M | $1.94B | $1.15B | $956.8M | $633.8M | $705.1M | $588.5M | $591.2M | $636.2M |
| Invested capital | $8.83B | $8.63B | $9.48B | $8.99B | $9.46B | $5.34B | $4.26B | $4.20B | $4.41B | $4.08B |
| Tangible asset value | $1.38B | $665.7M | $125.4M | −$747.8M | −$1.19B | −$33.0M | $485.2M | $258.3M | $56.5M | −$146.2M |
| Net current asset value | −$1.15B | −$1.53B | −$1.88B | −$2.72B | −$3.00B | −$1.47B | −$810.1M | −$833.5M | −$993.4M | −$1.10B |
| Graham number | $114.13 | $96.46 | $73.71 | $38.19 | $60.89 | $68.67 | $65.27 | $54.62 | $53.54 | $30.63 |
| Graham net-net per share | −$19.91 | −$23.07 | −$34.70 | −$34.74 | −$37.06 | −$21.51 | −$13.26 | −$13.33 | −$14.96 | −$15.91 |
| Capital allocation | ||||||||||
| Dividends paid | $241.8M | $219.9M | $200.6M | $183.5M | $163.2M | $133.8M | $123.0M | $112.5M | $102.9M | $93.2M |
| Share buybacks (net) | $235.5M | $211.3M | $11.8M | $308.6M | $55.8M | $14.6M | $51.2M | $81.5M | $65.5M | $97.5M |
| Dividend payout ratio | 30.8% | 35.8% | 53.0% | 171.4% | 66.9% | 33.7% | 30.2% | 37.0% | 35.4% | 84.7% |
| Dividends + buybacks / free cash flow | 49.1% | 55.4% | 34.6% | 124.6% | 55.1% | 33.0% | 46.3% | 55.5% | 57.6% | 75.9% |
| Capex / revenue | 6.2% | 6.8% | 7.0% | 8.0% | 6.8% | 7.7% | 7.1% | 6.8% | 6.3% | 6.6% |
| Capex / operating cash flow | 27.5% | 32.2% | 37.0% | 47.8% | 42.0% | 34.7% | 36.3% | 35.2% | 36.2% | 40.8% |
| Capex / depreciation | 0.76 | 0.78 | 0.64 | 0.65 | 0.52 | — | — | 0.84 | 0.93 | 0.92 |
| Stock-based compensation / revenue | 1.0% | 1.1% | 1.1% | 0.9% | 1.4% | 0.8% | 0.8% | 0.9% | 0.8% | 0.7% |
| R&D / revenue | 1.9% | 2.0% | 2.0% | 2.2% | 2.1% | 2.1% | 2.2% | 2.3% | 2.3% | 2.3% |
| SG&A / revenue | 23.7% | 24.2% | 23.9% | 23.6% | 26.4% | 23.5% | 23.6% | 24.1% | 23.5% | 25.0% |
| Efficiency | ||||||||||
| Days sales outstanding | 65.7 | 68.6 | 68.8 | 69.5 | 60.9 | 70.2 | 69.3 | 71.7 | 70.5 | 66.7 |
| Days of inventory on hand | 66.9 | 75.0 | 85.6 | 90.7 | 69.4 | 58.3 | 48.7 | 47.0 | 48.2 | 44.9 |
| Days payables outstanding | 34.2 | 31.8 | 33.2 | 36.1 | 29.8 | 31.7 | 32.2 | 32.8 | 32.2 | 31.4 |
| Cash conversion cycle (days) | 98.4 | 111.8 | 121.2 | 124.1 | 100.4 | 96.8 | 85.8 | 85.9 | 86.5 | 80.2 |
| Receivables turnover | 5.56 | 5.32 | 5.31 | 5.25 | 6.00 | 5.20 | 5.27 | 5.09 | 5.18 | 5.47 |
| Payables turnover | 10.68 | 11.48 | 10.99 | 10.11 | 12.23 | 11.52 | 11.32 | 11.13 | 11.34 | 11.62 |
| Inventory turnover | 5.46 | 4.87 | 4.26 | 4.02 | 5.26 | 6.26 | 7.50 | 7.76 | 7.57 | 8.12 |
| Asset turnover | 0.57 | 0.51 | 0.47 | 0.41 | 0.47 | 0.52 | 0.58 | 0.54 | 0.52 | 0.51 |
| Average receivables | $1.07B | $1.03B | $968.3M | $863.7M | $704.2M | $597.9M | $575.7M | $546.4M | $505.8M | $477.5M |
| Average payables | $309.8M | $266.2M | $265.7M | $252.7M | $191.3M | $153.1M | $151.1M | $144.4M | $134.7M | $136.5M |
| Average inventory | $606.6M | $627.9M | $685.0M | $635.2M | $445.0M | $281.7M | $228.3M | $207.0M | $201.8M | $195.3M |
| Intangibles / total assets | 54.2% | 58.6% | 55.9% | 63.2% | 67.7% | 59.7% | 53.8% | 57.7% | 60.8% | 60.0% |
Computed from STE's annual financial statements (latest annual report filed May 29, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
STE valuation and financial ratios
At the end of fiscal 2026 (March 31, 2026), Steris traded at 27.8 times earnings, against a 10-year median of 38.9. Based on the latest twelve months, the trailing P/E is 27.2 and the forward P/E is 19.2. Steris earned a return on equity of 11.4% and a return on invested capital of 9.5% in fiscal 2026. It ended the year with $2.1 billion of debt and $439.6 million in cash and short-term investments, net debt of $1.6 billion. It returned $477.3 million to shareholders: $241.8 million in dividends and $235.5 million in share buybacks, 49% of free cash flow. The share count rose 14.6% from 86.1M to 98.7M over 9 years.
See the STE income statement, the STE chart for price history, or the STE stock overview for the latest quote and news.
STE key metrics FAQ
What is Steris's P/E ratio?
Steris's trailing P/E ratio is 27.2 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 19.2. At the end of fiscal 2026 it was 27.8, compared with a 10-year median of 38.9.
What is Steris's EV/EBITDA?
Steris's enterprise value was 14.7 times EBITDA at the end of fiscal 2026 (enterprise value $23.5 billion, EBITDA $1.6 billion); the current EV/EBITDA is 13.4.
What is Steris's return on equity?
Steris's return on equity (ROE) was 11.4% in fiscal 2026: net income of $785.1 million on average shareholders' equity of $6.9 billion.
What is Steris's ROIC?
Steris's return on invested capital was 9.5% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Steris have?
Steris had total debt of $2.1 billion at the end of fiscal 2026, a debt-to-equity ratio of 0.29 and $1.6 billion of net debt (1.03 times EBITDA).
What is Steris's dividend yield?
Steris's forward dividend yield is 1.16%. Steris paid $241.8 million in dividends in fiscal 2026 ($2.45 per share), a payout ratio of 30.8%.
Does Steris buy back its shares?
Yes. Steris spent $235.5 million on net share repurchases in fiscal 2026 Shares outstanding changed −0.4% over the year, to 98.7M..
What is Steris's free cash flow yield?
Steris generated $972.4 million of free cash flow in fiscal 2026, a free cash flow yield of 4.5% on its market value at year-end ($21.8 billion).
What is Steris's current ratio?
Steris's current ratio was 2.09 at the end of fiscal 2026: current assets were 2.09 times current liabilities.